Bifidobacterium animalis AHC7 protects against pathogen-induced NF-κB activation in vivo.
about
Nucleotide-oligomerization-domain-2 affects commensal gut microbiota composition and intracerebral immunopathology in acute Toxoplasma gondii induced murine ileitisCausality of small and large intestinal microbiota in weight regulation and insulin resistanceBifidobacterium breve MCC-117 Induces Tolerance in Porcine Intestinal Epithelial Cells: Study of the Mechanisms Involved in the Immunoregulatory Effect.The impact of Toll-like-receptor-9 on intestinal microbiota composition and extra-intestinal sequelae in experimental Toxoplasma gondii induced ileitis.Gut microbiota, probiotics and diabetes.Immune response to Bifidobacterium bifidum strains support Treg/Th17 plasticity.Probiotics for the treatment of Clostridium difficile associated disease.Salmonella adhesion, invasion and cellular immune responses are differentially affected by iron concentrations in a combined in vitro gut fermentation-cell model.Characterisation of the bacterial community in expressed prostatic secretions from patients with chronic prostatitis/chronic pelvic pain syndrome and infertile men: a preliminary investigationAcute ileitis facilitates infection with multidrug resistant Pseudomonas aeruginosa in human microbiota-associated mice.Gut microbiota and the pathogenesis of insulin resistance.Regulation of toll-like receptors-mediated inflammation by immunobiotics in bovine intestinal epitheliocytes: role of signaling pathways and negative regulatorsThe commensal microbiota exacerbate infectious colitis in stressor-exposed mice.Immune modulating capability of two exopolysaccharide-producing Bifidobacterium strains in a Wistar rat model[Probiotics - is there evidence for use against antibiotic induced diarrhea, CDAD and travellers diarrhea?]
P2860
Q27314835-46878928-6E0E-4FED-8D88-808DB8AC6BEAQ28828501-AD6D46EB-353B-4073-90C4-AC9FAA2F23ADQ33666179-0CF73EB3-6B78-482C-A163-1FE90F3330B9Q33756071-A823C872-F985-445B-96D2-F5BFF376397AQ33831849-3ABE6D81-AB8E-4F78-BA88-056E6069F783Q34037796-19014463-1B65-4D54-88D9-FB28BF8EAED7Q34364074-09F5637F-2389-495D-8145-3A9E77183955Q35133715-B8F2994B-B4FF-45A0-9A89-756AD2C71EADQ37037530-75CCABF9-55AE-4649-AAB2-E47AD5C5FD3AQ37591557-39B98218-FFF6-4FE0-B501-36C74DE705C3Q37856877-14ADA0F5-23BB-46E9-B6BE-43537AEA396CQ38250324-C8C34D49-CD40-4189-890E-E891846A4266Q40538421-787462AB-E27F-4002-AD55-CBCC02C22F54Q40723316-B6DE61EC-09F3-40A5-9501-BCAAC2BB4566Q53765712-5145DEDC-8BE4-4A36-87F5-1A04DEB56C0E
P2860
Bifidobacterium animalis AHC7 protects against pathogen-induced NF-κB activation in vivo.
description
2010 nî lūn-bûn
@nan
2010 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Bifidobacterium animalis AHC7 protects against pathogen-induced NF-κB activation in vivo.
@ast
Bifidobacterium animalis AHC7 protects against pathogen-induced NF-κB activation in vivo.
@en
type
label
Bifidobacterium animalis AHC7 protects against pathogen-induced NF-κB activation in vivo.
@ast
Bifidobacterium animalis AHC7 protects against pathogen-induced NF-κB activation in vivo.
@en
prefLabel
Bifidobacterium animalis AHC7 protects against pathogen-induced NF-κB activation in vivo.
@ast
Bifidobacterium animalis AHC7 protects against pathogen-induced NF-κB activation in vivo.
@en
P2093
P2860
P356
P1433
P1476
Bifidobacterium animalis AHC7 protects against pathogen-induced NF-κB activation in vivo
@en
P2093
Barry Kiely
David Groeger
David O'Mahony
Frances O'Brien
Jeansoon Park
Liam O'Mahony
Mario Ziegler
Patrycja Konieczna
Paul Scully
Sharon Murphy
P2860
P2888
P356
10.1186/1471-2172-11-63
P577
2010-12-22T00:00:00Z
P5875
P6179
1013778285